Key facts
- CMPS - COMPASS Pathways plc has 20 insiders with reported activity on this page.
- No net insider buy/sell flow is currently reported for the last year.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 20 Insiders of COMPASS Pathways plc
- Symbol
- CMPS on Nasdaq
- Location
- Chesire, United Kingdom
Change
- No meaningful buy/sell imbalance is currently visible in the one-year window.
- Activity will update as new Forms 3/4/5 are filed.
Research use
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsInsider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 20 May 2025.
Buys
$0
Shares: 0
Insiders: 0
Sells
$0
Shares: 0
Insiders: 0
Net
$0
Shares: 0
Insiders: 0
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
COMPASS Pathways plc executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Atai Beckley N.V. | 10%+ Owner | $41,779,933 | Filing P/S | 26 Sep 2024 | ||
| George Jay Goldsmith | 10%+ Owner | $38,163,218 | Mixed | 24 Oct 2024 | ||
| Ekaterina Malievskaia | 10%+ Owner | $38,163,218 | Mixed | 24 Oct 2024 | ||
| Kabir Nath | Chief Executive Officer, Director | $2,532,231 | Mixed | 26 Mar 2026 | ||
| Teri Loxam | Chief Financial Officer | $1,048,813 | Mixed | 26 Mar 2026 | ||
| Matthew A. Owens | General Counsel & CLO | $471,973 | Mixed | 01 Feb 2024 | ||
| Michael Falvey | Chief Financial Officer | $187,893 | Mixed | 02 Feb 2023 | ||
| Annalisa Jenkins | Director | $134,022 | Mixed | 12 Jun 2025 | ||
| Mary-Rose Hughes | Interim CFO | $10,288 | Mixed | 01 Feb 2024 | ||
| Jason Camm | Director | Mixed | 01 Jan 2022 | |||
| Gino Santini | Director | Mixed | 12 Jun 2025 | |||
| Jeffrey M. Jonas | Director | Mixed | 29 Oct 2025 | |||
| David Y. Norton | Director | Mixed | 12 Jun 2025 | |||
| Justin D. Gover | Director | Mixed | 29 Jul 2025 | |||
| Daphne Karydas | Director | Mixed | 12 Jun 2025 | |||
| Robert McQuade | Director | Mixed | 12 Jun 2025 | |||
| Thomas Lonngren | Director | Mixed | 12 Jun 2025 | |||
| Wayne Joseph Riley | Director | Mixed | 12 Jun 2025 | |||
| Guy Goodwin | Chief Medical Officer | Mixed | 26 Mar 2026 | |||
| Linda McGoldrick | Director | Mixed | 12 Jun 2025 |
Top shareholders of COMPASS Pathways plc (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13D/G
13F
|
Company |
9.9%
|
12,971,571
|
$71,732,788 | +$19,339,372 | 31 Mar 2026 | |
| Deep Track Capital, LP |
13F
13D/G
|
Company |
10%
from 13D/G
|
12,161,496
|
$67,253,073 | — | 31 Mar 2026 | |
| Atai Beckley N.V. |
3/4/5
13D/G
|
10%+ Owner · ATAI Life Sciences N.V. |
6%
from 13D/G
|
6,905,774
|
$41,779,933 | — | 26 Sep 2024 | |
| Ekaterina Malievskaia |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
6,307,970
|
$38,163,218 | — | 24 Oct 2024 | |
| George Jay Goldsmith |
3/4/5
13D/G
|
10%+ Owner |
2.4%
from 13D/G
|
6,307,970
|
$38,163,218 | — | 24 Oct 2024 | |
| AtaiBeckley Inc. |
13D/G
|
— |
5%
|
4,764,710
|
$37,260,032 | $0 | 21 Jan 2026 | |
| MARSHALL WACE, LLP |
13F
|
Company |
3.1%
|
4,038,335
|
$22,331,992 | — | 31 Mar 2026 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
3.1%
|
4,002,200
|
$22,132,166 | — | 31 Mar 2026 | |
| Nantahala Capital Management, LLC |
13D/G
|
— |
3.6%
|
3,484,315
|
$19,965,125 | -$14,038,500 | 30 Sep 2025 | |
| BIT Capital GmbH |
13F
|
Company |
2.7%
|
3,491,234
|
$19,306,524 | — | 31 Mar 2026 | |
| ARK Investment Management LLC |
13F
|
Company |
2.5%
|
3,301,050
|
$18,254,806 | — | 31 Mar 2026 | |
| Vivo Opportunity Fund Holdings, L.P. |
13D/G
|
— |
3.2%
|
3,174,494
|
$18,189,851 | -$18,189,851 | 30 Sep 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2.4%
|
3,138,522
|
$17,356,027 | — | 31 Mar 2026 | |
| GMT CAPITAL CORP |
13F
|
Company |
2.3%
|
3,078,536
|
$17,024,304 | — | 31 Mar 2026 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
2%
|
2,583,499
|
$14,286,749 | — | 31 Mar 2026 | |
| TCG Crossover GP I, LLC |
13D/G
|
Chen Yu |
3.9%
|
3,858,000
|
$14,197,440 | $0 | 30 Jun 2025 | |
| DAFNA Capital Management LLC |
13F
|
Company |
1.8%
|
2,418,882
|
$13,376,417 | — | 31 Mar 2026 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
1.8%
|
2,344,720
|
$12,966,302 | — | 31 Mar 2026 | |
| Eagle Health Investments LP |
13F
|
Company |
1.6%
|
2,060,427
|
$11,394,161 | — | 31 Mar 2026 | |
| NEXTBio Capital Management LP |
13F
|
Company |
1.5%
|
2,021,407
|
$11,178,381 | — | 31 Mar 2026 | |
| INTEGRATED CORE STRATEGIES (US) LLC |
13D/G
|
Millennium Management LLC |
3%
|
2,773,521
|
$10,456,174 | -$2,412,525 | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
1.4%
|
1,855,070
|
$10,258,537 | — | 31 Mar 2026 | |
| Caption Management, LLC |
13F
|
Company |
1.2%
|
1,610,130
|
$8,904,019 | — | 31 Mar 2026 | |
| Sio Capital Management, LLC |
13F
|
Company |
1.1%
|
1,506,525
|
$8,331,083 | — | 31 Mar 2026 | |
| HEIGHTS CAPITAL MANAGEMENT, INC |
13F
|
Company |
1.1%
|
1,492,415
|
$8,253,055 | — | 31 Mar 2026 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
1.1%
|
1,467,362
|
$8,114,512 | — | 31 Mar 2026 | |
| Aisling Capital Management LP |
13F
|
Company |
1.1%
|
1,432,336
|
$7,920,818 | — | 31 Mar 2026 | |
| PFM Health Sciences, LP |
13F
|
Company |
1%
|
1,367,099
|
$7,560,057 | — | 31 Mar 2026 | |
| MORGAN STANLEY |
13F
|
Company |
0.92%
|
1,205,887
|
$6,668,557 | — | 31 Mar 2026 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.88%
|
1,150,646
|
$6,363,072 | — | 31 Mar 2026 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.86%
|
1,122,588
|
$6,207,912 | — | 31 Mar 2026 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.85%
|
1,108,483
|
$6,129,911 | — | 31 Mar 2026 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
0.8%
|
1,045,000
|
$5,778,850 | — | 31 Mar 2026 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.76%
|
1,000,000
|
$5,530,000 | — | 31 Mar 2026 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.72%
|
948,554
|
$5,245,504 | — | 31 Mar 2026 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.66%
|
865,354
|
$4,785,408 | — | 31 Mar 2026 | |
| Creek Drive Management Group LLC |
13F
|
Company |
0.63%
|
825,000
|
$4,562,250 | — | 31 Mar 2026 | |
| Kalehua Capital Management LLC |
13F
|
Company |
0.63%
|
819,692
|
$4,532,897 | — | 31 Mar 2026 | |
| CITADEL ADVISORS LLC |
13D/G
13F
|
Kenneth Griffin · Company |
1.7%
|
1,166,576
|
$4,397,992 | $0 | 31 Dec 2024 | |
| Propel Bio Management, LLC |
13F
|
Company |
0.57%
|
742,049
|
$4,117,846 | — | 31 Mar 2026 | |
| BlackRock, Inc. |
13F
|
Company |
0.52%
|
683,241
|
$3,778,323 | — | 31 Mar 2026 | |
| Eversept Partners, LP |
13F
|
Company |
0.52%
|
677,924
|
$3,748,920 | — | 31 Mar 2026 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.52%
|
675,000
|
$3,732,750 | — | 31 Mar 2026 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.44%
|
570,496
|
$3,154,843 | — | 31 Mar 2026 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.42%
|
554,411
|
$3,065,893 | — | 31 Mar 2026 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.37%
|
487,674
|
$2,696,837 | — | 31 Mar 2026 | |
| Kabir Nath |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
734,805
mixed-class rows
|
$2,532,231 | — | 26 Mar 2026 | |
| Jump Financial, LLC |
13F
|
Company |
0.35%
|
455,000
|
$2,516,150 | — | 31 Mar 2026 | |
| CenterBook Partners LP |
13F
|
Company |
0.31%
|
409,237
|
$2,263,081 | — | 31 Mar 2026 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.29%
|
382,086
|
$2,112,936 | — | 31 Mar 2026 |
Recent Insider Transactions by Companies or Individuals for COMPASS Pathways plc
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Kabir Nath | CMPS | Ordinary Shares | Award | 91.2% | 175,000 | 366,990 | 26 Mar 2026 | Direct | ||
| Kabir Nath | CMPS | Share Option (Right to Buy) | Award | 367,815 | 367,815 | 26 Mar 2026 | Direct | |||
| Guy Goodwin | CMPS | Share Option (Right to Buy) | Award | 170,600 | 115,600 | 26 Mar 2026 | Direct | |||
| Teri Loxam | CMPS | Ordinary Shares | Award | 97.4% | 75,000 | 152,002 | 26 Mar 2026 | Direct | ||
| Teri Loxam | CMPS | Share Option (Right to Buy) | Award | 157,635 | 157,635 | 26 Mar 2026 | Direct | |||
| Kabir Nath | CMPS | Ordinary Shares | Tax liability | -6.4% | -13,131 | 191,990 | 11 Mar 2026 | Direct | ||
| Teri Loxam | CMPS | Ordinary Shares | Tax liability | -2.26% | -1,781 | 77,002 | 11 Mar 2026 | Direct | ||
| Teri Loxam | CMPS | Ordinary Shares | Tax liability | -5.37% | -4,467 | 78,783 | 02 Mar 2026 | Direct | ||
| Kabir Nath | CMPS | Ordinary Shares | Tax liability | -7.31% | -16,181 | 205,121 | 02 Feb 2026 | Direct | ||
| Jeffrey M. Jonas | CMPS | Share Option (Right to Buy) | Award | 52,000 | 52,000 | 29 Oct 2025 | Direct | |||
| Kabir Nath | CMPS | Ordinary Shares | Tax liability | -2.8% | -6,366 | 221,302 | 01 Aug 2025 | Direct | ||
| Justin D. Gover | CMPS | Share Option (Right to Buy) | Award | 52,000 | 52,000 | 29 Jul 2025 | Direct | |||
| Gino Santini | CMPS | Share Option (Right to Buy) | Award | 39,000 | 39,000 | 12 Jun 2025 | Direct | |||
| Wayne Joseph Riley | CMPS | Share Option (Right to Buy) | Award | 26,000 | 26,000 | 12 Jun 2025 | Direct | |||
| David Y. Norton | CMPS | Share Option (Right to Buy) | Award | 26,000 | 26,000 | 12 Jun 2025 | Direct | |||
| Robert McQuade | CMPS | Share Option (Right to Buy) | Award | 26,000 | 26,000 | 12 Jun 2025 | Direct | |||
| Linda McGoldrick | CMPS | Share Option (Right to Buy) | Award | 26,000 | 26,000 | 12 Jun 2025 | Direct | |||
| Thomas Lonngren | CMPS | Share Option (Right to Buy) | Award | 26,000 | 26,000 | 12 Jun 2025 | Direct | |||
| Daphne Karydas | CMPS | Share Option (Right to Buy) | Award | 26,000 | 26,000 | 12 Jun 2025 | Direct | |||
| Annalisa Jenkins | CMPS | Share Option (Right to Buy) | Award | 26,000 | 26,000 | 12 Jun 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.